Peter J. O’Hanlon

2.0k citations

69 papers · 1.6k indexed · h-index 23

Impact in

Microbiology top 2%
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria

Papers in

Microbiology 7
Organic Chemistry 31
- Synthetic Organic Chemistry Methods 10
- Synthesis of β-Lactam Compounds 7
- Synthesis and biological activity 5

Co-authors: Lucy Mensah Richard L. Jarvest Andrew J. Pope Andrew K. Forrest N. J. P. BROOM Murray J. B. Brown P. C. T. HANNAN P. H. BENTLEY
Journals: Bioorganic & Medicinal Chemistry Letters (16 papers)Journal of the Chemical Society Perkin Transactions 1 (12 papers)The Journal of Antibiotics (7 papers)Tetrahedron Letters (5 papers)Tetrahedron (3 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Peter J. O’Hanlon

69 papers receiving 1.6k citations

Peers

Countries citing papers authored by Peter J. O’Hanlon

Since Specialization

Citations

This map shows the geographic impact of Peter J. O’Hanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. O’Hanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. O’Hanlon more than expected).

Fields of papers citing papers by Peter J. O’Hanlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. O’Hanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. O’Hanlon. The network helps show where Peter J. O’Hanlon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter J. O’Hanlon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter J. O’Hanlon Line = papers co-authored together Peter J. O’Hanlon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SAR of biphenyl carboxamide ligands of the human melanin-concentrating hormone receptor 1 (MCH R1): Discovery of antagonist SB-568849 Bioorganic & Medicinal Chemistry Letters ·David R. Witty, John H. Bateson, Guillaume Hervieu, Philip D. Jeffrey, Christopher N. Johnson, Alison I. Muir, Peter J. O’Hanlon, Geoffrey Stemp, 半田伸夫, Kevin M. Thewlis, Shelagh Wilson, Kim Winborn	2006	12
2	Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849 Bioorganic & Medicinal Chemistry Letters ·David R. Witty, John H. Bateson, Guillaume Hervieu, Kamal Albarazanji, Philip D. Jeffrey, Dieter Hamprecht, Andrea Haynes, Christopher N. Johnson, Alison I. Muir, Peter J. O’Hanlon, Geoffrey Stemp, 半田伸夫, Kevin M. Thewlis, Kim Winborn	2006	18
3	Conformational restriction of methionyl tRNA synthetase inhibitors leading to analogues with potent inhibition and excellent gram-Positive antibacterial activity Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, John M. Berge, Pamela Brown, C. S. V. HOUGE‐FRYDRYCH, Peter J. O’Hanlon, Мария Викторовна Дугарова, Andrew J. Pope, Stephen Rittenhouse	2003	22
4	Synthesis and activity of analogues of the isoleucyl tRNA synthetase inhibitor SB-203207 Bioorganic & Medicinal Chemistry ·Curtis F. Crasto, Andrew K. Forrest, Tomislav Karoli, Darren R. March, Lucy Mensah, Peter J. O’Hanlon, Michael R. Nairn, Geomayra Mishell Rebolledo Zhingre, Latiffa Anggraini, Martin G. Banwell, Christopher J. Easton	2003	13
5	Lipopeptide substrates for SpsB, the Staphylococcus aureus type I signal peptidase: design, conformation and conversion to α-ketoamide inhibitors European Journal of Medicinal Chemistry ·Gordon Bruton, Anthony Huxley, Peter J. O’Hanlon, Barry S. Orlek, Drake S. Eggleston, John Eric Humphries, Simon A. Readshaw, Andrew B. West, Stephen Ashman, Murray J. B. Brown, Keith M. Moore, Andrew J. Pope, Karen O’Dwyer, Wenxin Wang	2003	47
6	Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, John M. Berge, Murray J. B. Brown, Pamela Brown, Ebrahim Pazokinejad, Andrew K. Forrest, C. S. V. HOUGE‐FRYDRYCH, Peter J. O’Hanlon, Мария Викторовна Дугарова, Stephen Rittenhouse, Robert J. Sheppard	2003	32
7	Inhibitors of Bacterial Tyrosyl tRNA Synthetase: Synthesis of Carbocyclic Analogues of the Natural Product SB-219383 Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, John M. Berge, C. S. V. HOUGE‐FRYDRYCH, Lucy Mensah, Peter J. O’Hanlon, Andrew J. Pope	2001	10
8	Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383 Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, John M. Berge, Pamela Brown, Dieter Hamprecht, Мария Викторовна Дугарова, Lucy Mensah, Peter J. O’Hanlon, Andrew J. Pope	2001	18
9	Inhibitors of bacterial tyrosyl tRNA synthetase: synthesis of four stereoisomeric analogues of the natural product SB-219383 Bioorganic & Medicinal Chemistry Letters ·John M. Berge, Royston C. B. Copley, Drake S. Eggleston, Dieter Hamprecht, Richard L. Jarvest, Lucy Mensah, Peter J. O’Hanlon, Andrew J. Pope	2000	28
10	Synthesis and Activity of Analogues of SB-219383. Novel Potent Inhibitors of Bacterial Tyrosyl tRNA Synthetase. The Journal of Antibiotics ·John M. Berge, N. J. P. BROOM, C. S. V. HOUGE‐FRYDRYCH, Richard L. Jarvest, Lucy Mensah, Мария Викторовна Дугарова, Peter J. O’Hanlon, Andrew J. Pope, Stephen Rittenhouse	2000	20
11	Aminoalkyl adenylate and aminoacyl sulfamate intermediate analogues differing greatly in affinity for their cognate Staphylococcus aureus aminoacyl tRNA synthetases Bioorganic & Medicinal Chemistry Letters ·Andrew K. Forrest, Richard L. Jarvest, Lucy Mensah, Peter J. O’Hanlon, Partha Pratim Mondal, Robert J. Sheppard	2000	54
12	Interaction of tyrosyl aryl dipeptides with S. aureus tyrosyl tRNA synthetase: Inhibition and crystal structure of a complex Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, John M. Berge, C. S. V. HOUGE‐FRYDRYCH, Cheryl A. Janson, Lucy Mensah, Peter J. O’Hanlon, Andrew J. Pope, Adrian Saldanha, Xiayang Qiu	1999	10
13	Molecular recognition of tyrosinyl adenylate analogues by prokaryotic tyrosyl tRNA synthetases Bioorganic & Medicinal Chemistry ·Pamela Brown, Myung-Hee Mun, Lucy Mensah, Peter J. O’Hanlon, Neal F. Osborne, Andrew J. Pope, Graham C. Walker	1999	46
14	Characterization of Isoleucyl-tRNA Synthetase from Staphylococcus aureus Journal of Biological Chemistry ·Andrew J. Pope, Keith J. M. Moore, Mary McVey, Lucy Mensah, Neil Benson, A Toupouri, N. J. P. BROOM, Murray J. B. Brown, Peter J. O’Hanlon	1998	49
15	Anti-infectives : recent advances in chemistry and structure-activity relationships P. H. BENTLEY, Peter J. O’Hanlon	1997	48
16	Chemistry of Pseudomonic Acid. Part 16. Aryl and Heteroaryl Ketone Derivatives of Monic Acid. The Journal of Antibiotics ·Chris Breakton, N. J. P. BROOM, N. V. Ravi Kumar Majeti, Ebrahim Pazokinejad, Andrew K. Forrest, P. C. T. HANNAN, Rashmi Ramakrishnan, Peter J. O’Hanlon, N. B. Chougule, Neil D. Pearson, Albert Appuhn, J. M. Wilson	1996	6
17	The Chemistry of Pseudomonic Acid. Part 14. Synthesis and In Vivo Biological Activity of Heterocyclyl Substituted Oxazole Derivatives. The Journal of Antibiotics ·N. J. P. BROOM, Ebrahim Pazokinejad, P. C. T. HANNAN, Albert Appuhn, Peter J. O’Hanlon, Graham C. Walker, J. M. Wilson, Sigrid A. Friese	1995	27
18	SB 205952, a novel semisynthetic monic acid analog with at least two modes of action Antimicrobial Agents and Chemotherapy ·DANIEL E. COSTELLO, B Oliva, Robert Cassels, Peter J. O’Hanlon, I. Chopra	1995	17
19	Structure-activity relationships in a series of piperazine2,3-dione containing penicillins and cephalosporins. II. Derivatives substituted at N(4) of the piperazine ring. The Journal of Antibiotics ·Frank P. Harrington, James K. Varney, Peter J. O’Hanlon, Robert Southgate	1989	5
20	Antimycoplasmal activities of the speudomonic acids and structure-activity relationships of monic acid A derivatives. The Journal of Antibiotics ·Tanvi Sonune, L McIntyre, P. C. T. HANNAN, Peter J. O’Hanlon, Bin Xu	1988	2

About Peter J. O’Hanlon

Peter J. O’Hanlon is a scholar working on Microbiology, Organic Chemistry, Pharmacology, Molecular Medicine and Molecular Biology, having authored 69 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (22 papers), Microbial Natural Products and Biosynthesis (11 papers), Chemical Synthesis and Analysis (10 papers), Synthetic Organic Chemistry Methods (10 papers), Synthesis of β-Lactam Compounds (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Genomics and Phylogenetic Studies (6 papers) and Synthesis and biological activity (5 papers). The work is most often cited by research in Microbiology (176 citations), Molecular Medicine (124 citations), Organic Chemistry (685 citations), Pharmacology (304 citations) and Molecular Biology (888 citations). Peter J. O’Hanlon has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Lucy Mensah, Richard L. Jarvest, Andrew J. Pope, Andrew K. Forrest, N. J. P. BROOM, Murray J. B. Brown, P. C. T. HANNAN, P. H. BENTLEY, John M. Berge and Stephen Rittenhouse. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of the Chemical Society Perkin Transactions 1, The Journal of Antibiotics, Tetrahedron Letters and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact